These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21245746)

  • 1. Risk of recurrent venous thromboembolism according to malignancy characteristics in patients with cancer-associated thrombosis: a systematic review of observational and intervention studies.
    Louzada ML; Majeed H; Dao V; Wells PS
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):86-91. PubMed ID: 21245746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of low- molecular- weight- heparin versus vitamin K antagonists for long term treatment of cancer-associated venous thromboembolism in adults: a systematic review of randomized controlled trials.
    Louzada ML; Majeed H; Wells PS
    Thromb Res; 2009 Apr; 123(6):837-44. PubMed ID: 18977517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis.
    Ross JA; Miller MM; Rojas Hernandez CM
    Thromb Res; 2017 Feb; 150():86-89. PubMed ID: 28064037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: A cohort study.
    Donadini MP; Dentali F; Pegoraro S; Pomero F; Brignone C; Guasti L; Steidl L; Ageno W
    Vasc Med; 2017 Dec; 22(6):518-524. PubMed ID: 28732457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours.
    Chai-Adisaksopha C; Linkins LA; ALKindi SY; Cheah M; Crowther MA; Iorio A
    Thromb Haemost; 2017 Feb; 117(3):589-594. PubMed ID: 28078351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term anticoagulation treatment for acute venous thromboembolism in patients with and without cancer. The SWIss Venous ThromboEmbolism Registry (SWIVTER) II.
    Spirk D; Ugi J; Korte W; Husmann M; Hayoz D; Baldi T; Frauchiger B; Banyai M; Aujesky D; Baumgartner I; Kucher N
    Thromb Haemost; 2011 Jun; 105(6):962-7. PubMed ID: 21475778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose escalation of low molecular weight heparin in patients with recurrent cancer-associated thrombosis.
    Ihaddadene R; Le Gal G; Delluc A; Carrier M
    Thromb Res; 2014 Jul; 134(1):93-5. PubMed ID: 24835673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism.
    Louzada ML; Carrier M; Lazo-Langner A; Dao V; Kovacs MJ; Ramsay TO; Rodger MA; Zhang J; Lee AY; Meyer G; Wells PS
    Circulation; 2012 Jul; 126(4):448-54. PubMed ID: 22679142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K Antagonists Compared to Low-Molecular-Weight Heparins for Treatment of Cancer-Associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice. An Observational Study in Routine Clinical Practice.
    den Exter PL; Hooijer J; van der Hulle T; van Oosten JP; Dekkers OM; Klok FA; Huisman MV
    Thromb Haemost; 2017 Nov; 117(11):2163-2167. PubMed ID: 28981552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of venous thromboembolism in ambulatory cancer patients in Germany: a prospective non-interventional study.
    Matzdorff A; Schilling H; Ledig B
    Oncol Res Treat; 2015; 38(4):174-80. PubMed ID: 25877941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of venous thromboembolism among patients with primary lung cancer.
    Chew HK; Davies AM; Wun T; Harvey D; Zhou H; White RH
    J Thromb Haemost; 2008 Apr; 6(4):601-8. PubMed ID: 18208538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of recurrent venous thromboembolism and bleeding on anticoagulation.
    Menapace LA; McCrae KR; Khorana AA
    Thromb Res; 2016 Apr; 140 Suppl 1():S93-8. PubMed ID: 27067987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tinzaparin and VKA use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
    Noel-Savina E; Sanchez O; Descourt R; André M; Leroyer C; Meyer G; Couturaud F
    Thromb Res; 2015 Jan; 135(1):78-83. PubMed ID: 25466839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in patients with venous thromboembolism and five common sites of cancer.
    Martín-Martos F; Trujillo-Santos J; Del Toro J; Bura-Riviere A; Lorenzo A; Barillari G; Soler S; Mahè I; Sahuquillo JC; Monreal M;
    Thromb Res; 2017 Mar; 151 Suppl 1():S16-S20. PubMed ID: 28262228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of a pharmacist-managed anticoagulation service for breast cancer patients.
    Jones KL; Barnett C; Gauthier M; Boster B; Espirito JL; Michaud LB
    J Oncol Pharm Pract; 2012 Mar; 18(1):122-7. PubMed ID: 21364079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism in patients with cancer: an overview for pharmacists using a case-based approach.
    Pangilinan JM
    J Pharm Pract; 2010 Aug; 23(4):294-302. PubMed ID: 21507829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic stroke in cancer patients treated with direct oral anticoagulants for venous thromboembolism.
    Gon Y; Sakaguchi M; Takasugi J; Mochizuki H
    Thromb Res; 2017 Jun; 154():16-18. PubMed ID: 28384442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.
    Romera-Villegas A; Cairols-Castellote MA; Vila-Coll R; Martí-Mestre X; Colomé E; Iguaz I
    Ann Vasc Surg; 2010 Jul; 24(5):628-39. PubMed ID: 19932949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.